X
Cancer Innovation (CI) is a scholarly journal dedicated to publishing research in the field of Pharmacology, Toxicology and Pharmaceutics, and Published by John Wiley & Sons. The Print-ISSN of Cancer Innovation is 27709191
The Publication fees (APC) is 2700 USD; 2250 GBP; 2590 EUR.
Cancer Innovation is published by John Wiley & Sons, based in United Kingdom, publishing since 2022. It covers research in Pharmacology, Toxicology and Pharmaceutics, Nursing, Medicine, Biochemistry Genetics and Molecular Biology.
Topics covered include oncology, medical engineering, translational medicine, computational science, tumour multiomics, carcinogenesis.
The journal is indexed in Scopus, DOAJ; it uses a anonymous peer review process.
Article processing charge: 2700 USD; 2250 GBP; 2590 EUR.
For full aims and scope, see the journal's official page.
| Journal title | Cancer Innovation (CI) |
| Print ISSN | 27709191 |
| Online ISSN | 27709183 |
| Publisher Name | John Wiley & Sons |
| Subject Category | Pharmacology, Toxicology and Pharmaceutics |
| Access type | 🟢 Open Access |
| Status | 🟢 Active |
In the context of academic journals, "Metrics and Rankings" refer to various measures and evaluations used to assess the quality, influence, and impact of a journal.
Below are the metrics and rankings for the journal Cancer Innovation
| Article Publication Charges (APC) |
2700 USD; 2250 GBP; 2590 EUR ✳️Without APC Pharmacology, Toxicology and Pharmaceutics Journals |
Abstracting and Indexing (A&I) refers to the processes that help organize and categorize academic journals, making them easier to find and access for researchers and scholars
If you would like to submit a manuscript or visit the journal's website, please click on the link below.
| Journal Submission | 🔗 Journal Website |
Add the app to your device for one-tap access.
